Prot #CO40016: A Double-Blind, Placebo-Controlled, Randomized Phase III Study Of Ipatasertib In Combination With Paclitaxel As A Treatment For Patients With Pik3ca/Akt1/Pten-Altered, Locally Advanced Or Metastatic, Triple-Negative Breast Cancer Or Hormone

Project: Research project

Project Details

StatusFinished
Effective start/end date4/19/18 → 4/19/21

Funding

  • Syneos Health, Inc. (Prot #CO40016)
  • Genentech, Inc. (Prot #CO40016)